RTI Surgical is a global leader in tissue engineering and medical device manufacturing, specialising in regenerative solutions that improve surgical outcomes and patient care.

RTI Surgical, headquartered in Alachua, Florida, is a leading medical technology company focused on developing innovative biologic, metal, and synthetic implants. With a commitment to advancing healthcare, RTI partners with surgeons and healthcare providers worldwide to deliver high-quality, safe, and effective solutions for a variety of surgical procedures. The company’s proprietary Tutoplast® process, a sterilisation technique for tissue products, sets a benchmark for safety and reliability in regenerative medicine.

RTI serves multiple therapeutic areas, including orthopaedics, sports medicine, plastic and reconstructive surgery, and general surgery. As a trusted contract development and manufacturing organisation (CDMO), RTI collaborates with healthcare innovators to design, develop, and produce life-enhancing medical solutions.

Key Products and Services:

• Biologics:
  • Cortiva® Allograft Dermis for soft tissue repair.
  • Sterilised tissue implants for regenerative medicine.
• Medical Devices:
  • Synthetic and metal implants for various surgical applications.
• Proprietary Processes:
  • Tutoplast® Tissue Sterilisation Process for tissue safety.
  • Advanced manufacturing techniques ensuring product quality.
• Contract Development and Manufacturing Services (CDMO):
  • Customised medical device and implant production.
  • Collaboration in product development and innovation.

With a strong focus on safety, innovation, and patient care, RTI Surgical continues to pioneer advancements in tissue engineering and medical device manufacturing. By leveraging its expertise and global reach, the company remains dedicated to supporting healthcare providers and improving the quality of life for patients worldwide.